An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

Published in

  • Arthritis & Rheumatology

Time

Date/time value

  • 2018

Identity

Digital Object Identifier (DOI)

  • 10.1002/art.40546

Additional Document Info

Parent Title

  • ARTHRITIS & RHEUMATOLOGY

Volume

  • 70

Issue

  • 10

Publisher

  • John Wiley & Sons